In November 2013, US-based Merck’s patent on hair loss treatment Propecia (made up of Finasteride 1mg) ultimately expired. Thereafter, numerous generic versions of propecia im test <a href="http://finasteride.us.com/#finasteride-jbbs.shitaraba.net">finasteride</a> from roll in into the US market at a selfish fraction of the expense of Propecia.
